A GLP-1 analog lowers ER stress and enhances protein folding to ameliorate homocysteine-induced endothelial dysfunction
At the highest dose, participants lost an average of 17.5% of their body weight in just 24 weeks
By the end of this post, you will gain a clearer understanding of your options and feel more confident in pursuing a path to sustainable weight loss supported by science, empathy, and a transparent approach
Tirzepatide is a dual GIP and GLP-1 receptor agonist, a peptide that mirrors two natural hormones your body releases after eating
The information provided in this article is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment
Tirzepatide 10 and 15 mg also decreased large triglyceride-rich lipoprotein particles, small low-density lipoprotein particles, and lipoprotein insulin resistance score [60]